We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.1B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$4.21B
AUM Growth
+$64.6M
Cap. Flow
-$99.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19

Top Buys

1
CELG
Celgene Corp
CELG
+$36.1M
2
ADT
ADT Corp
ADT
+$34.9M
3
PFE icon
Pfizer
PFE
+$27.7M
4
CB icon
Chubb
CB
+$19.3M
5
JCI icon
Johnson Controls International
JCI
+$15.1M

Top Sells

1
LO
LORILLARD INC COM STK
LO
+$79.3M
2
MCRS
MICROS SYSTEMS INC
MCRS
+$73.6M
3
MSI icon
Motorola Solutions
MSI
+$51M
4
BHC icon
Bausch Health
BHC
+$23.5M
5
DTV
DIRECTV COM STK (DE)
DTV
+$15.9M

Sector Composition

1 Healthcare 26.94%
2 Consumer Discretionary 15.2%
3 Industrials 15.12%
4 Financials 11.91%
5 Technology 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PM icon
26
Philip Morris
PM
$299B
$61.5M 1.46%
729,970
– –
MA icon
27
Mastercard
MA
$478B
$54.1M 1.29%
736,125
-300
-0% -$22.3K
NLSN
28
DELISTED
Nielsen Holdings plc
NLSN
$46.9M 1.11%
968,860
+765
+0.1% +$35.6K
BCR
29
DELISTED
CR Bard Inc.
BCR
$45.8M 1.09%
320,130
– –
MTD icon
30
Mettler-Toledo International
MTD
$26.5B
$42M 1%
165,910
– –
CELG
31
DELISTED
Celgene Corp
CELG
$40.7M 0.97%
+474,120
New +$36.1M
ADT
32
DELISTED
ADT Corp
ADT
$38.1M 0.91%
+1,090,090
New +$34.9M
SCL icon
33
Stepan Co
SCL
$1.32B
$36.1M 0.86%
682,013
-23,277
-3% -$1.31M
RMD icon
34
ResMed
RMD
$28.9B
$33.3M 0.79%
658,470
+90,710
+16% +$4.5M
PAG icon
35
Penske Automotive Group
PAG
$13.3B
$32.7M 0.78%
659,832
-159,578
-19% -$7.28M
PLKI
36
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
$27.1M 0.65%
621,053
+356,664
+135% +$14.5M
SENEA icon
37
Seneca Foods Class A
SENEA
$1.17B
$27.1M 0.64%
885,561
– –
TUP
38
DELISTED
Tupperware Brands Corporation
TUP
$26.8M 0.64%
319,665
+540
+0.2% +$45.4K
VYX icon
39
NCR Voyix
VYX
$1.1B
$26.7M 0.64%
1,241,693
+595,048
+92% +$12M
CAH icon
40
Cardinal Health
CAH
$54.1B
$26M 0.62%
379,625
+15,310
+4% +$1.04M
MCHP icon
41
Microchip Technology
MCHP
$44.4B
$23.1M 0.55%
947,360
-2,000
-0.2% -$47.7K
WTW icon
42
Willis Towers Watson
WTW
$27.7B
$23M 0.55%
200,141
+19,043
+11% +$2.14M
CNK icon
43
Cinemark Holdings
CNK
$3.55B
$22M 0.52%
621,980
+25,255
+4% +$773K
OPLN
44
Openlane
OPLN
$4.19B
$20.6M 0.49%
1,711,871
+1,216
+0.1% +$14K
SBH icon
45
Sally Beauty Holdings
SBH
$1.43B
$18.5M 0.44%
735,766
– –
WMB icon
46
Williams Companies
WMB
$90B
$16.6M 0.39%
285,075
-42,675
-13% -$1.98M
NUS icon
47
Nu Skin
NUS
$254M
$16.3M 0.39%
221,015
+38,135
+21% +$3.01M
TFX icon
48
Teleflex
TFX
$5.99B
$15.2M 0.36%
144,330
-55
-0% -$5.77K
FMER
49
DELISTED
FIRSTMERIT CORP
FMER
$15M 0.36%
760,365
+182,210
+32% +$3.57M
APAM icon
50
Artisan Partners
APAM
$2.73B
$14.5M 0.34%
255,770
+73,095
+40% +$4.18M
1
2
3 4 5

Similar funds

VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Nicholas Company's Q2 2014 Portfolio in Review

As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
  • Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
  • Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
  • Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
  • Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
  • Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
  • Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.